Table 2. Difference between epidemiological characteristics of vancomycin-susceptible and vancomycin-resistant Enterococcus faecium bacteraemias, Switzerland, 2016–2018 (n = 1,112 bacteraemias).
| Characteristic | VSE bacteraemia (n = 1,085) |
VRE bacteraemia (n = 27) |
p value | |
|---|---|---|---|---|
| Age – year, median (IQR) | 70 (55–75) | 65 (55–75) | 0.60 | |
| Male sex – n (%) | 685 (63.1) | 15 (55.6) | 0.55 | |
| Department – n (%) | ICU | 210 (19.4) | 7 (25.9) | 0.55 |
| Non-ICU | 875 (80.6) | 20 (74.1) | ||
| Hospital – n (%) | University hospital | 573 (52.8) | 17 (63.0) | 0.40 |
| Community hospital | 512 (47.2) | 10 (37.0) | ||
| Hospital size – n (%) | > 400 beds | 619 (57.1) | 19 (70.4) | 0.27 |
| 200–400 beds | 267 (24.6) | 6 (22.2) | ||
| < 200 beds | 199 (18.3) | 2 (7.4) | ||
| Geographic region – n (%) | South-west | 420 (38.7) | 9 (33.3) | 0.71 |
| North-east | 665 (61.3) | 18 (66.7) | ||
| Year – n (%) | 2016 | 357 (32.9) | 4 (14.8) | cf trend analysisa |
| 2017 | 382 (35.2) | 9 (33.3) | ||
| 2018 | 346 (31.9) | 14 (51.9) | ||
ICU: intensive care unit; IQR: interquartile range; VRE: vancomycin resistant Enterococcus faecium; VSE: vancomycin susceptible Enterococcus faecium.
a For detailed analysis, see trend data.